Commentary Open Access
Volume 3 | Issue 3 | DOI: https://doi.org/10.33696/cancerimmunol.3.051

Anti-PD1 Therapy in Lynch Syndrome-associated Recurrent Glioblastoma

  • 1Senior Associate Consultant, Assistant Professor, Departments of Neurology and Neurosurgery, Mayo Clinic Florida, 4500 San Pablo Rd. S., Jacksonville, FL 32224, USA
+ Affiliations - Affiliations

Corresponding Author

Wendy J Sherman, Sherman.Wendy@mayo.edu

Received Date: July 07, 2021

Accepted Date: August 23, 2021

Author Information X